Intel has reportedly agreed to buy the semiconductor technology developer in a $250m deal that will provide exits to AMD, Samsung and GlobalFoundries.

The acquisition of Wayne State University spinout RetroSense followed a licensing agreement with University of California, San Diego for another compound and may yet exceed $60m.

Novo and others are set to reinvest in Apollo Endosurgery after it agreed to acquire Nasdaq-listed Lpath in a deal that will speed up its progress towards an initial public offering.

Santen Pharmaceutical and Nerveda RetroSense have exited eye disease treatment developer RetroSense, which had raised about $12m in funding.

Vision processing chipmaker Movidius, which had raised more than $86m from investors including Robert Bosch and Sunny Optical, has been acquired for an undisclosed sum.

Allergan has acquired the Wayne State University spinout, backed by Santen Pharmaceutical and Nerveda, for an upfront payment of $60m with potential milestone payments in future.

The insurer's AXA Strategic Ventures unit has exited email contacts tool developer EverContact through an acquisition by One More Company, in which it has also invested.

Rakuten has acquired Fablic, the operator of a flea market app called Fril, providing an exit to Colopl and Cookpad, which backed a $9.2m series A round two years ago.